Avantor (AVTR)
(Delayed Data from NYSE)
$24.29 USD
-0.50 (-2.02%)
Updated May 13, 2024 04:00 PM ET
After-Market: $24.28 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Avantor, Inc. (AVTR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$27.71 | $30.00 | $22.00 | 14.08% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Avantor, Inc. comes to $27.71. The forecasts range from a low of $22.00 to a high of $30.00. The average price target represents an increase of 11.78% from the last closing price of $24.79.
Analyst Price Targets (17)
Broker Rating
Avantor, Inc. currently has an average brokerage recommendation (ABR) of 1.55 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 19 brokerage firms. The current ABR compares to an ABR of 1.55 a month ago based on 19 recommendations.
Of the 19 recommendations deriving the current ABR, 12 are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 63.16% and 15.79% of all recommendations. A month ago, Strong Buy made up 63.16%, while Buy represented 15.79%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 12 | 12 |
Buy | 3 | 3 | 3 | 3 | 3 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/29/2024 | William Blair | Matt Larew | Hold | Hold |
4/29/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
4/29/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
4/4/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
10/27/2023 | KeyBanc Capital Markets | Paul Knight | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.55 |
ABR (Last week) | 1.55 |
# of Recs in ABR | 19 |
Average Target Price | $27.71 |
LT Growth Rate | 16.30% |
Industry | Medical Services |
Industry Rank by ABR | 90 of 252 |
Current Quarter EPS Est: | 0.24 |